Background: Assays that account for the biological properties and fragmentation of cell-free DNA (cfDNA) can improve the performance of liquid biopsy. However, preanalytic and physiological differences between individuals on fragmentomic analysis are poorly defined. Methods: We analyzed the impact of collection tube, plasma processing time, and physiology on the size distribution of cfDNA, their genome-wide representation, and sequence diversity at the cfDNA fragment ends using shallow whole-genome sequencing. Results: Neither different stabilizing collection tubes nor processing times affected the cfDNA fragment sizes, but could impact the genome-wide fragmentation patterns and fragment-end sequences of cfDNA. In addition, beyond differenc...
Despite the growing interest in circulating cell-free DNA (ccfDNA) analysis in various clinical fiel...
While tissue biopsy has for the longest time been the gold-standard in biomedicine, precision/person...
Cell-free DNA (cfDNA) is short, extracellular, fragmented double-stranded DNA found in plasma. Plasm...
Background: Assays that account for the biological properties and fragmentation of cell-free DNA (cf...
Pre-analytical factors can significantly affect circulating cell-free DNA (cfDNA) analysis. However,...
Analysis of cell-free DNA (cfDNA) in the blood has shown promise for monitoring a variety of biologi...
To unequivocally address their unresolved intimate structures in blood, we scrutinized the size dist...
Noninvasive sampling of an individual’s body fluids is an easy means to capture circulating cell-fre...
Aim: The fragmentation characteristics of cell-free DNA (cfDNA) are informative biomarkers in liquid...
Cell-free DNA (cfDNA) emerges as a promising liquid biopsy biomarker for cancer diagnosis and patien...
Cell-free DNA molecules are released into the plasma via apoptotic or necrotic events and active rel...
Cell-free DNA (cfDNA) emerges as a promising liquid biopsy biomarker for cancer diagnosis and patien...
Existing methods to improve detection of circulating tumor DNA (ctDNA) have focused on genomic alter...
<div><p>The breadth of diagnostic procedures that utilize cell free DNA (cfDNA) from human plasma ha...
The release of fetoplacental cell-free DNA (cfDNA) into the maternal bloodstream opened up new avenu...
Despite the growing interest in circulating cell-free DNA (ccfDNA) analysis in various clinical fiel...
While tissue biopsy has for the longest time been the gold-standard in biomedicine, precision/person...
Cell-free DNA (cfDNA) is short, extracellular, fragmented double-stranded DNA found in plasma. Plasm...
Background: Assays that account for the biological properties and fragmentation of cell-free DNA (cf...
Pre-analytical factors can significantly affect circulating cell-free DNA (cfDNA) analysis. However,...
Analysis of cell-free DNA (cfDNA) in the blood has shown promise for monitoring a variety of biologi...
To unequivocally address their unresolved intimate structures in blood, we scrutinized the size dist...
Noninvasive sampling of an individual’s body fluids is an easy means to capture circulating cell-fre...
Aim: The fragmentation characteristics of cell-free DNA (cfDNA) are informative biomarkers in liquid...
Cell-free DNA (cfDNA) emerges as a promising liquid biopsy biomarker for cancer diagnosis and patien...
Cell-free DNA molecules are released into the plasma via apoptotic or necrotic events and active rel...
Cell-free DNA (cfDNA) emerges as a promising liquid biopsy biomarker for cancer diagnosis and patien...
Existing methods to improve detection of circulating tumor DNA (ctDNA) have focused on genomic alter...
<div><p>The breadth of diagnostic procedures that utilize cell free DNA (cfDNA) from human plasma ha...
The release of fetoplacental cell-free DNA (cfDNA) into the maternal bloodstream opened up new avenu...
Despite the growing interest in circulating cell-free DNA (ccfDNA) analysis in various clinical fiel...
While tissue biopsy has for the longest time been the gold-standard in biomedicine, precision/person...
Cell-free DNA (cfDNA) is short, extracellular, fragmented double-stranded DNA found in plasma. Plasm...